Prior to this, Maria held multiple roles at Novartis including Head of Global Manufacturing Functions, and Global Head of Manufacturing, Science & Technology
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
Dr. Rizo brings extensive industry leadership experience to Vividion, having held multiple senior executive roles during her career at both biotechnology and large pharmaceutical companies.
Most recently, she served as chief human resources officer at Vyripharm Enterprises.
Brings 25 years of global operations and supply chain experience to Piramal
Guindo will be responsible for leading the development and implementation of the company’s long-term strategy for the Human Health portfolio.
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
We see significant potential in working with oncolytic virus companies and Neo antigen-companies
Gilman will be responsible for all business development and portfolio strategy efforts globally.
New Director supports NASDAQ rule on diversity
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
Company hires life science veteran Jessica Cao to join management team
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
AstraZeneca also played a critical role in the global response to COVID-19.
Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
Auld is a seasoned Financial Executive with over 30 years of relevant experience
Subscribe To Our Newsletter & Stay Updated
